Coherus Oncology (CHRS) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Coherus Oncology (CHRS) over the last 12 years, with Q3 2025 value amounting to 0.58.
- Coherus Oncology's Asset Utilization Ratio rose 21109.67% to 0.58 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.58, marking a year-over-year increase of 21109.67%. This contributed to the annual value of 0.5 for FY2024, which is 688.74% up from last year.
- Coherus Oncology's Asset Utilization Ratio amounted to 0.58 in Q3 2025, which was up 21109.67% from 0.67 recorded in Q2 2025.
- Coherus Oncology's 5-year Asset Utilization Ratio high stood at 0.67 for Q2 2025, and its period low was 0.19 during Q3 2024.
- In the last 5 years, Coherus Oncology's Asset Utilization Ratio had a median value of 0.46 in 2021 and averaged 0.46.
- Per our database at Business Quant, Coherus Oncology's Asset Utilization Ratio plummeted by 5339.57% in 2024 and then soared by 21109.67% in 2025.
- Over the past 5 years, Coherus Oncology's Asset Utilization Ratio (Quarter) stood at 0.46 in 2021, then fell by 10.98% to 0.41 in 2022, then increased by 3.65% to 0.42 in 2023, then surged by 32.06% to 0.56 in 2024, then rose by 3.77% to 0.58 in 2025.
- Its last three reported values are 0.58 in Q3 2025, 0.67 for Q2 2025, and 0.66 during Q1 2025.